Baxter International Inc.

Baxter International Inc. provides a broad portfolio of healthcare products primarily in the United States. Its operations are structured into three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Key offerings include sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company also provides advanced equipment for surgical spaces, such as operating room integration technologies and precision positioning devices, as well as specialty injectable pharmaceuticals and drug compounding services. These products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and by patients at home under physician supervision.

Baxter International Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol BAX. The company trades in US Dollars (USD), reflecting its primary listing in the United States. As a US-based company, its financial reporting and stock transactions are conducted in USD, making it accessible to investors on major US exchanges.

Baxter International Inc. operates in the Healthcare sector and is classified under the Medical Instruments & Supplies industry. This means the company focuses on producing medical devices, equipment, and supplies used in healthcare settings. Its products range from intravenous solutions and infusion systems to surgical equipment and patient monitoring technologies, all of which fall under the broader category of medical instruments and supplies.

Baxter International Inc. is headquartered in Deerfield, Illinois, United States. The company was incorporated in 1931. While its primary market is the United States, Baxter operates globally, serving customers in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Its products are used in various healthcare settings, including hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients' homes under physician supervision.

Baxter International distributes its healthcare products through multiple channels, including a direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. This multi-channel approach allows the company to reach a wide range of customers, from large hospital systems to individual patients at home. The distribution network supports Baxter's diverse product portfolio, which includes sterile IV solutions, infusion systems, surgical equipment, and injectable pharmaceuticals, ensuring availability across various healthcare settings in the United States and internationally.